参考文献/References:
[1] 王陇德,王金环,彭 斌,等. 《中国脑卒中防治报告2016》概要[J]. 中国脑血管病杂志,2017,14(4):217-224.
[2] 董 强,郭起浩,罗本燕,等. 卒中后认知障碍管理专家共识[J]. 中国卒中杂志,2017,12(6):519-531.
[3] 王 莉.醒脑静注射液治疗脑梗死急性期非痴呆型血管性认知功能障碍疗效观察[J].陕西中医,2017,38(8):989-990.
[4] 王旭霞,巩尊科,陈 伟,等. 脑卒中认知障碍患者MRS与简易精神状态量表的相关性研究[J]. 中国现代医药杂志,2014,6(5):40-43.
[5] Mijajlovi MD,Pavlovi A,Brainin M,et al. Post-stroke dementia-a comprehensive review[J]. BMC Medicine,2017,15(1):11.
[6] 张 虹,屈秋民,刘 军,等.脑梗塞患者白质疏松的磁共振波谱研究[J].陕西医学杂志,2008,37(6):703-705.
[7] 中华医学会神经病医学会. 中国急性缺血性脑卒中诊治指标2014[J].中华神经科杂志,2015,48(4):246-257.
[8] Novotny JR,Fulbright RK,Pearl PL,et al. Magnetic resonance spectroscopy of neurotransmitters in human brain[J]. Ann Neurol,2003,54(6):25-31.
[9] Kantarci K. Proton MRS in mild cognitive impairment[J]. Journal of Magnetic Resonance Imaging,2013,37(4):1-11.
[10] 齐德明.磁共振波谱成像的研究进展[J].影像研究与医学应用,2017,1(15):5-6.
[11] Chen HM,Lin HF,Huang MF,et al. Validation oftaiwan performance-based instrumental activities of daily living(tpiadl),a performance- based measurement of instrumental activities of daily living for patients with vascular cognitive impairment[J]. Plos One,2016,11(11):166546.
[12] Zhang N,Song X,Bartha R,et al. Advances in high-field magnetic resonance spectroscopy in alzheimer's disease[J]. Current Alzheimer Research,2014,11(4):367-388.
[13] Cheng LL,Newell K,Mallory,et al.Quantification of neurons in Alzheimer and control brains with ex vivo high resolution magic angle spinning proton magnetiv resonance spectroscopy and stereology[J]. Magnetic Resonance Imaging,2002,20(7):527-533.
[14] Rotondo E,Bruschetta G,Sacca A,et al. Straightforward relative quantitation and age-related human standars of N-acetylaspartate at the centrum semiovale level by CSI1H-MRS[J]. Magn Reson Imaging,2003,21(9):1055-1060.
[15] Zhang L,Sui RB. Proton magnetic resonance spectroscopy study on the metabolism changes of cerebellum in patients with post-stroke depression[J]. Cellular Physiology and Biochemistry,2017,41(4):1393-1402.
[16] Mackay S,Meyerhoff DJ,Constans JM,et al. Regional gray and white matter metabolite differences in subjects with AD,with subcortical ischemic vascular dementia,and elderly controls with 1H magnetic resonance spectroscopic imaging[J]. Archives of Neurology,1996,53(2):167-174.